MetLife Investment Management’s EyePoint Inc EYPT Stock Holding History

MetLife Investment Management’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$560K	Buy	43,469 +1,670	+4%	+$25K	﹤0.01%	1693
2025 Q4	$764K	Buy	41,799 +2,081	+5%	+$29.5K	﹤0.01%	1581
2025 Q3	$566K	Hold	39,718	–	–	﹤0.01%	1747
2025 Q2	$374K	Hold	39,718	–	–	﹤0.01%	1815
2025 Q1	$215K	Sell	39,718 -784	-2%	-$5.49K	﹤0.01%	2160
2024 Q4	$302K	Buy	40,502 +11,217	+38%	+$104K	﹤0.01%	2070
2024 Q3	$234K	Hold	29,285	–	–	﹤0.01%	2208
2024 Q2	$255K	Buy	29,285 +10,106	+53%	+$141K	﹤0.01%	2097
2024 Q1	$396K	Buy	19,179 +5,206	+37%	+$129K	﹤0.01%	1804
2023 Q4	$323K	Hold	13,973	–	–	﹤0.01%	1949
2023 Q3	$112K	Hold	13,973	–	–	﹤0.01%	2525
2023 Q2	$122K	Buy	+13,973	New	+$85.3K	﹤0.01%	2569
2022 Q4	–	Sell	-12,835	Closed	-$102K	–	2834
2022 Q3	$102K	Hold	12,835	–	–	﹤0.01%	2676
2022 Q2	$101K	Hold	12,835	–	–	﹤0.01%	2710
2022 Q1	$156K	Buy	12,835 +4,582	+56%	+$50.2K	﹤0.01%	2494
2021 Q4	$101K	Buy	+8,253	New	+$111K	﹤0.01%	2403

Other funds holding EYPT

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

MetLife Investment Management's EYPT Position: Q1 2026 in Review

MetLife Investment Management increased its EyePoint Inc (EYPT) stake by 4% in Q1 2026, buying an estimated $25K and bringing the position to 43,469 shares worth $560K. The position accounts for ﹤0.01% of the portfolio, ranked #1693.

MetLife Investment Management first reported a position in EYPT in Q4 2021 and has held it in 16 quarters since. The position peaked at $764K in Q4 2025. 188 funds tracked by Wall St. Rank hold EYPT as of Q1 2026.

MetLife Investment Management held 43,469 shares of EyePoint Inc worth $560K as of Q1 2026.
MetLife Investment Management bought 1,670 EyePoint Inc shares in Q1 2026, an estimated $25K.
EyePoint Inc made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1693 holding.
MetLife Investment Management first reported a position in EyePoint Inc in Q4 2021 and has held it in 16 quarters since.
MetLife Investment Management's EyePoint Inc position peaked at $764K in Q4 2025.
188 funds tracked by Wall St. Rank held EyePoint Inc as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.